Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Inc."

508 News Found

JLN Medical College launches robotic surgery programme in Rajasthan
Hospitals | June 17, 2026

JLN Medical College launches robotic surgery programme in Rajasthan

The launch event brought together policymakers, healthcare leaders, surgeons, and members of the medical fraternity to discuss the transformative role of robotic-assisted surgery


Dr Reddy’s launches first-to-market generic Bosutinib in US oncology push
News | June 15, 2026

Dr Reddy’s launches first-to-market generic Bosutinib in US oncology push

Dr Reddy’s has partnered with MSN Laboratories Private Limited on the product, with Dr Reddy’s holding exclusive US marketing rights while MSN leads development and manufacturing


Arihant Innochem launches state-of-the-art research & innovation centre in Navi Mumbai
News | June 15, 2026

Arihant Innochem launches state-of-the-art research & innovation centre in Navi Mumbai

The new facility aims to accelerate formulation science and application-led research across pharma, biopharma, nutraceuticals, personal care, and home care segments


Punita Kumar-Sinha appointed Independent Director at Aurobindo Pharma USA
People | June 09, 2026

Punita Kumar-Sinha appointed Independent Director at Aurobindo Pharma USA

Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors


Agappe Diagnostics appoints Rahul Raman Nair as CHRO
People | June 06, 2026

Agappe Diagnostics appoints Rahul Raman Nair as CHRO

Rahul brings over 17 years of experience in human resources leadership across the healthcare, banking, information technology, and FMCG sectors


Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies
News | June 05, 2026

Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies

Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments


Glenmark launches generic Lacosamide Injection USP in US Market
News | June 05, 2026

Glenmark launches generic Lacosamide Injection USP in US Market

Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually


Lupin and Natco get FDA approval for Eribulin Mesylate injection
Drug Approval | June 03, 2026

Lupin and Natco get FDA approval for Eribulin Mesylate injection

Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials is the bioequivalent to the reference listed drug (RLD) Halaven injection of Eisai, Inc.


Granules Pharmaceuticals receives USFDA EIR for Chantilly facility
News | June 03, 2026

Granules Pharmaceuticals receives USFDA EIR for Chantilly facility

This facility plays an important role in Granules’ global manufacturing and supply network


Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention
News | May 27, 2026

Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention

Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.